Affiliation:
1. Department of Pharmaceutical Chemistry, College of Pharmacy, Madras Medical College, Affiliated to “The Tamil Nadu Dr. M.G.R Medical University” Chennai - 600 003, Tamil, Nadu,India
Abstract
Background:
Tuberculosis, is a chronic infectious disease, affects one third of the global population. Emergence
of Multi-resistant (MDR) strains and high susceptibility of human immunodeficiency virus (HIV) infected persons to the
disease forced to develop novel anti-tuberculosis agents and preferably have a novel mechanism of action as to avoid crossresistant with other agents. Literature survey evidences that, Pyridine, Thiadiazole , Benzimidazole; and Acetyl thiophene
derivatives exhibit various pharmacological activities, including anti-mycobacterial activity.
Methods:
Thus, a series of Pyridine, Thiadiazole, Benzimidazole; and Acetyl thiophene based molecules were designed and
docked against crucial mtb enzyme target InhA (Enoyl Acyl Carrier Protein Reductase) Enzyme. The docked molecules
were screened against good docking-score and multiple interactions and opted for synthesis. Synthesized molecules were re
crystallized to obtain the purity. All the purified compounds were characterized by various spectral analyses and evaluated
for anti- mycobacterial activity against tuberculosis H37RV strain by Microplate Alamar Blue Assay (MABA) method.
Results:
The experimental results shown that schiff base of Pyridine (Compounds ‘d’ ) and Benzimidazole derivatives
(Compounds ‘i’ ) possesses good anti-tubercular activity with a MIC below 1.6 μg /mL. Further compound ‘e’ of
benzimdazole derivative showed good anti tubercular activity with an MIC below 6.25 μg /mL. Whereas 2 - acetyl thiopene
compounds exhibited moderate anti tubercular activity at below 50μg/mL.
Conclusion:
The comparative in vitro and molecular docking study analysis reveals that, compared to chalcones of Acetyl
thiophne derivatives, Pyridine, thiadazole and Benzimidazole based schiff bases exhibited best anti tubercular activity.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,General Medicine
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献